よむ、つかう、まなぶ。
「日本人の食事摂取基準（2025年版）」策定検討会報告書 (288 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_44138.html |
| 出典情報 | 「日本人の食事摂取基準（2025年版）」策定検討会報告書（10／11）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
130) Fine KD, Santa Ana CA, Fordtran JS. Diagnosis of magnesium-induced diarrhea. N Engl J Med.
1991;324(15):1012-1017.
131) Marken PA, Weart CW, Carson DS, et al. Effects of magnesium oxide on the lipid profile of healthy
volunteers. Atherosclerosis. 1989;77(1):37-42.
132) Ricci JM, Hariharan S, Helfgott A, et al. Oral tocolysis with magnesium chloride: a randomized controlled
prospective clinical trial. Am J Obstet Gynecol. 1991;165(3):603-610.
133) Geleijnse JM, Witteman JC, den Breeijen JH, et al. Dietary electrolyte intake and blood pressure in older
subjects: the Rotterdam Study. J Hypertens. 1996;14(6):737-741.
134) Kass L, Weekes J, Carpenter L. Effect of magnesium supplementation on blood pressure: a meta-analysis.
Eur J Clin Nutr. 2012;66(4):411-418.
135) Mizushima S, Cappuccio FP, Nichols R, et al. Dietary magnesium intake and blood pressure: a qualitative
overview of the observational studies. J Hum Hypertens. 1998;12(7):447-453.
136) Dickinson HO, Nicolson DJ, Campbell F, et al. Magnesium supplementation for the management of
essential hypertension in adults. Cochrane Database Syst Rev. 2006;(3):CD004640.
137) Zhang X, Li Y, Del Gobbo LC, et al. Effects of magnesium supplementation on blood pressure: A metaanalysis of randomized double-blind placebo-controlled trials. Hypertension. 2016;68(2):324-333.
138) Dibaba DT, Xun P, Song Y, et al. The effect of magnesium supplementation on blood pressure in individuals
with insulin resistance, prediabetes, or noncommunicable chronic diseases: a meta-analysis of randomized
controlled trials. Am J Clin Nutr. 2017;106(3):921-929.
139) Banjanin N, Belojevic G. Relationship of dietary magnesium intake and serum magnesium with
hypertension: a review. Magnes Res. 2021;34(4):166-171.
140) Dong JY, Xun P, He K, et al. Magnesium intake and risk of type 2 diabetes: meta-analysis of prospective
cohort studies. Diabetes Care. 2011;34(9):2116-2122.
141) Fang X, Han H, Li M, et al. Dose-response relationship between dietary magnesium intake and risk of type
2 diabetes mellitus: A systematic review and meta-regression analysis of prospective cohort studies.
Nutrients. 2016;8(11):739.
142) Nanri A, Mizoue T, Noda M, et al. Magnesium intake and type II diabetes in Japanese men and women: the
Japan Public Health Center-based Prospective Study. Eur J Clin Nutr. 2010;64(10):1244-1247.
143) Jiao Y, Li W, Wang L, et al. Relationship between dietary magnesium intake and metabolic syndrome.
Nutrients. 2022;14(10):2013.
144) Yu W, Luying S, Haiyan W, et al. Importance and benefits of dietary sodium restriction in the management
of chronic kidney disease patients: experience from a single Chinese center. Int Urol Nephrol.
2012;44(2):549-556.
145) Slagman MCJ, Waanders F, Hemmelder MH, et al. Moderate dietary sodium restriction added to angiotensin
converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure:
randomised controlled trial. BMJ. 2011;343(jul26 2):d4366.
146) 小川愛一郎, 川口良人. 高燐・低燐血症. 医学と薬学. 1989;22:321-328.
147) Bergwitz C, Jüppner H. Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23. Annu Rev
Med. 2010;61(1):91-104.
148) Anderson JJB. Nutritional biochemistry of calcium and phosphorus. J Nutr Biochem. 1991;2(6):300-307.
278
1991;324(15):1012-1017.
131) Marken PA, Weart CW, Carson DS, et al. Effects of magnesium oxide on the lipid profile of healthy
volunteers. Atherosclerosis. 1989;77(1):37-42.
132) Ricci JM, Hariharan S, Helfgott A, et al. Oral tocolysis with magnesium chloride: a randomized controlled
prospective clinical trial. Am J Obstet Gynecol. 1991;165(3):603-610.
133) Geleijnse JM, Witteman JC, den Breeijen JH, et al. Dietary electrolyte intake and blood pressure in older
subjects: the Rotterdam Study. J Hypertens. 1996;14(6):737-741.
134) Kass L, Weekes J, Carpenter L. Effect of magnesium supplementation on blood pressure: a meta-analysis.
Eur J Clin Nutr. 2012;66(4):411-418.
135) Mizushima S, Cappuccio FP, Nichols R, et al. Dietary magnesium intake and blood pressure: a qualitative
overview of the observational studies. J Hum Hypertens. 1998;12(7):447-453.
136) Dickinson HO, Nicolson DJ, Campbell F, et al. Magnesium supplementation for the management of
essential hypertension in adults. Cochrane Database Syst Rev. 2006;(3):CD004640.
137) Zhang X, Li Y, Del Gobbo LC, et al. Effects of magnesium supplementation on blood pressure: A metaanalysis of randomized double-blind placebo-controlled trials. Hypertension. 2016;68(2):324-333.
138) Dibaba DT, Xun P, Song Y, et al. The effect of magnesium supplementation on blood pressure in individuals
with insulin resistance, prediabetes, or noncommunicable chronic diseases: a meta-analysis of randomized
controlled trials. Am J Clin Nutr. 2017;106(3):921-929.
139) Banjanin N, Belojevic G. Relationship of dietary magnesium intake and serum magnesium with
hypertension: a review. Magnes Res. 2021;34(4):166-171.
140) Dong JY, Xun P, He K, et al. Magnesium intake and risk of type 2 diabetes: meta-analysis of prospective
cohort studies. Diabetes Care. 2011;34(9):2116-2122.
141) Fang X, Han H, Li M, et al. Dose-response relationship between dietary magnesium intake and risk of type
2 diabetes mellitus: A systematic review and meta-regression analysis of prospective cohort studies.
Nutrients. 2016;8(11):739.
142) Nanri A, Mizoue T, Noda M, et al. Magnesium intake and type II diabetes in Japanese men and women: the
Japan Public Health Center-based Prospective Study. Eur J Clin Nutr. 2010;64(10):1244-1247.
143) Jiao Y, Li W, Wang L, et al. Relationship between dietary magnesium intake and metabolic syndrome.
Nutrients. 2022;14(10):2013.
144) Yu W, Luying S, Haiyan W, et al. Importance and benefits of dietary sodium restriction in the management
of chronic kidney disease patients: experience from a single Chinese center. Int Urol Nephrol.
2012;44(2):549-556.
145) Slagman MCJ, Waanders F, Hemmelder MH, et al. Moderate dietary sodium restriction added to angiotensin
converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure:
randomised controlled trial. BMJ. 2011;343(jul26 2):d4366.
146) 小川愛一郎, 川口良人. 高燐・低燐血症. 医学と薬学. 1989;22:321-328.
147) Bergwitz C, Jüppner H. Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23. Annu Rev
Med. 2010;61(1):91-104.
148) Anderson JJB. Nutritional biochemistry of calcium and phosphorus. J Nutr Biochem. 1991;2(6):300-307.
278